Literature DB >> 11867736

Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death.

Laurence E Cheng1, Claes Ohlén, Brad H Nelson, Philip D Greenberg.   

Abstract

Multiple cytokines, including IL-2, can affect T cell proliferation and survival. However, IL-2 can lead to apoptosis as well as proliferation, making unclear whether IL-2 receptor (IL-2R) signals ultimately have a predominantly positive or negative effect. To address this issue, we examined the effect of enhancing IL-2R signals in CD8(+) T cells after antigen stimulation by engineering a transgenic (Tg) mouse strain with CD8(+) T cells capable of augmented, regulated, autocrine IL-2R signaling after target recognition by means of expression of a chimeric granulocyte-macrophage colony-stimulating factor (GM-CSF)/IL-2R. The Tg CD8(+) T cells can bind the granulocyte-macrophage colony-stimulating GM-CSF produced by antigen stimulation, but the GM-CSF binding results in delivery of an IL-2R signal. After antigen stimulation in vivo, the Tg T cells demonstrated marked increases in the initial proliferative response and cell expansion and displayed continued increases in cell expansion after repeated antigen exposure. These data suggest that the predominant role of IL-2R signals delivered to responding CD8(+) T cells is to set the size of the initial response to antigen by promoting T cell proliferation and survival and not cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867736      PMCID: PMC122462          DOI: 10.1073/pnas.052676899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  IL-15 and IL-2: a matter of life and death for T cells in vivo.

Authors:  X C Li; G Demirci; S Ferrari-Lacraz; C Groves; A Coyle; T R Malek; T B Strom
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

2.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

3.  A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection.

Authors:  H Bassiri; S R Carding
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

4.  Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms.

Authors:  M Wolf; A Schimpl; T Hünig
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

5.  Control of homeostasis of CD8+ memory T cells by opposing cytokines.

Authors:  C C Ku; M Murakami; A Sakamoto; J Kappler; P Marrack
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

Review 6.  The dynamics of the cellular immune response to HIV infection: implications for vaccination.

Authors:  A J McMichael; M Callan; V Appay; T Hanke; G Ogg; S Rowland-Jones
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-08-29       Impact factor: 6.237

7.  IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice.

Authors:  J Marks-Konczalik; S Dubois; J M Losi; H Sabzevari; N Yamada; L Feigenbaum; T A Waldmann; Y Tagaya
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

8.  Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Authors:  L Van Parijs; Y Refaeli; J D Lord; B H Nelson; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

9.  Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation.

Authors:  A W Goldrath; L Y Bogatzki; M J Bevan
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  The pleiotropic functions of interleukin 15: not so interleukin 2-like after all.

Authors:  A Ma; D L Boone; J P Lodolce
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  25 in total

Review 1.  Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.

Authors:  William Y Ho; Cassian Yee; Philip D Greenberg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.

Authors:  Yi Zhou; Huimei Chen; Li Liu; Xueqing Yu; Galina K Sukhova; Min Yang; Lijun Zhang; Vasileios C Kyttaris; George C Tsokos; Isaac E Stillman; Takaharu Ichimura; Joseph V Bonventre; Peter Libby; Guo-Ping Shi
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

3.  Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells.

Authors:  Matthew R Buckwalter; Pramod K Srivastava
Journal:  Cancer Immun       Date:  2013-01-15

4.  Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.

Authors:  Aki Furusawa; John Reiser; Kavitha Sadashivaiah; Haley Simpson; Arnob Banerjee
Journal:  J Immunother       Date:  2018 Feb/Mar       Impact factor: 4.456

5.  IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor.

Authors:  Yuying Liu; Nannan Zhou; Li Zhou; Jing Wang; Yabo Zhou; Tianzhen Zhang; Yi Fang; Jinwei Deng; Yunfeng Gao; Xiaoyu Liang; Jiadi Lv; Zhenfeng Wang; Jing Xie; Yuanbo Xue; Huafeng Zhang; Jingwei Ma; Ke Tang; Yiliang Fang; Feiran Cheng; Chengjuan Zhang; Bing Dong; Yuzhou Zhao; Peng Yuan; Quanli Gao; Haizeng Zhang; F Xiao-Feng Qin; Bo Huang
Journal:  Nat Immunol       Date:  2021-01-11       Impact factor: 25.606

6.  Assessment of TCR signal strength of antigen-specific memory CD8+ T cells in human blood.

Authors:  Hanchih Wu; Ashley Witzl; Hideki Ueno
Journal:  Blood Adv       Date:  2019-07-23

7.  Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response.

Authors:  Li-Xin Wang; Suyu Shu; Mary L Disis; Gregory E Plautz
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

8.  Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.

Authors:  Robert H Mealey; Matt H Littke; Steven R Leib; William C Davis; Travis C McGuire
Journal:  Vet Immunol Immunopathol       Date:  2007-07-25       Impact factor: 2.046

9.  Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.

Authors:  Shinichiro Fuse; Weijun Zhang; Edward J Usherwood
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

Review 10.  Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.

Authors:  Michael Kalos; Carl H June
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.